Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2009

Open Access 01-12-2009 | Review

XVII International AIDS Conference: From Evidence to Action - Basic science

Authors: David Gilden, Rodney Kort

Published in: Journal of the International AIDS Society | Special Issue 1/2009

Login to get access

Abstract

This article focuses on the sessions in which basic science research was presented at the XVII International AIDS Conference (AIDS 2008). It also provides an analysis of basic science issues which generated significant discussion and debate at the conference and are likely to have implications for future laboratory and clinical research. Data presented at AIDS 2008 confirmed the speed with which HIV establishes latent viral reservoirs following infection and the resulting challenges to viral eradication given how effectively HIV proviral RNA inserts itself into human DNA within these reservoirs. Studies also raised questions about the source of residual viremia and how these might be targeted by novel therapeutic approaches.
Literature
1.
go back to reference Bhaskaran K, et al: Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008, 300: 51-59. 10.1001/jama.300.1.51.CrossRefPubMed Bhaskaran K, et al: Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008, 300: 51-59. 10.1001/jama.300.1.51.CrossRefPubMed
2.
go back to reference Antiretroviral Therapy Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008, 372: 293-299. 10.1016/S0140-6736(08)61113-7.CrossRef Antiretroviral Therapy Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008, 372: 293-299. 10.1016/S0140-6736(08)61113-7.CrossRef
3.
go back to reference Siliciano R: HIV Persistence on patients on HAART: re-evaluating prospects for eradication. Plenary Session, XVII International AIDS Conference. 2008, August , WEPL0101 Siliciano R: HIV Persistence on patients on HAART: re-evaluating prospects for eradication. Plenary Session, XVII International AIDS Conference. 2008, August , WEPL0101
4.
go back to reference Fauci A: The future of HIV research. Special Session, XVII International AIDS Conference. 2008, August , WESS0101 Fauci A: The future of HIV research. Special Session, XVII International AIDS Conference. 2008, August , WESS0101
5.
go back to reference Sreenath K, et al: Repression of HIV-1 LTR promoter by nuclear matrix protein SMAR1 promotes proviral latency. Abstract Session, XVII International AIDS Conference. 2008, August , WEAA0105 Sreenath K, et al: Repression of HIV-1 LTR promoter by nuclear matrix protein SMAR1 promotes proviral latency. Abstract Session, XVII International AIDS Conference. 2008, August , WEAA0105
6.
go back to reference Hunter E: Determinants of HIV transmission. Symposium, XVII International AIDS Conference. 2008, August , MOSY0602 Hunter E: Determinants of HIV transmission. Symposium, XVII International AIDS Conference. 2008, August , MOSY0602
7.
go back to reference Boeras D, et al: HIV in genital fluids during heterosexual transmission. Abstract Session, XVII International AIDS Conference. 2008, August , MOAA0302 Boeras D, et al: HIV in genital fluids during heterosexual transmission. Abstract Session, XVII International AIDS Conference. 2008, August , MOAA0302
8.
go back to reference Ganor Y, et al: The mechanism of sexual transmission of human immunodeficiency virus (HIV-1) via the foreskin epithelium. Abstract Session, XVII International AIDS Conference. 2008, , MOAA0301 Ganor Y, et al: The mechanism of sexual transmission of human immunodeficiency virus (HIV-1) via the foreskin epithelium. Abstract Session, XVII International AIDS Conference. 2008, , MOAA0301
9.
go back to reference Geijtenbeek TB, et al: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000, 100: 587-597. 10.1016/S0092-8674(00)80694-7.CrossRefPubMed Geijtenbeek TB, et al: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000, 100: 587-597. 10.1016/S0092-8674(00)80694-7.CrossRefPubMed
10.
go back to reference de Witte L, Nabatov A, Geijtenbeek TB: Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends in Molecular Medicine. 2008, 14: 12-19. 10.1016/j.molmed.2007.11.001.CrossRefPubMed de Witte L, Nabatov A, Geijtenbeek TB: Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends in Molecular Medicine. 2008, 14: 12-19. 10.1016/j.molmed.2007.11.001.CrossRefPubMed
11.
go back to reference Kaldensjö T, et al: Ectocervical expression of C-type lectin receptors in HIV exposed uninfected women. Abstract Session, XVII International AIDS Conference. 2008, August , WEAA0204 Kaldensjö T, et al: Ectocervical expression of C-type lectin receptors in HIV exposed uninfected women. Abstract Session, XVII International AIDS Conference. 2008, August , WEAA0204
12.
go back to reference Mehandru S, et al: Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. Journal of Experimental Medicine. 2004, 200: 761-70. 10.1084/jem.20041196.PubMedCentralCrossRefPubMed Mehandru S, et al: Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. Journal of Experimental Medicine. 2004, 200: 761-70. 10.1084/jem.20041196.PubMedCentralCrossRefPubMed
13.
go back to reference Brenchley JM, et al: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. Journal of Experimental Medicine. 2004, 200: 749-759. 10.1084/jem.20040874.PubMedCentralCrossRefPubMed Brenchley JM, et al: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. Journal of Experimental Medicine. 2004, 200: 749-759. 10.1084/jem.20040874.PubMedCentralCrossRefPubMed
14.
go back to reference Chun TW, et al: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. Journal of Infectious Diseases. 2008, 197: 714-720. 10.1086/527324.CrossRefPubMed Chun TW, et al: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. Journal of Infectious Diseases. 2008, 197: 714-720. 10.1086/527324.CrossRefPubMed
15.
go back to reference Pimenta-Inada HK, et al: The toll-like receptor 2 ligand zymosan inhibits HIV-1 replication in human primary cells. Abstract Session, XVII International AIDS Conference. 2008, August , MOAA0105 Pimenta-Inada HK, et al: The toll-like receptor 2 ligand zymosan inhibits HIV-1 replication in human primary cells. Abstract Session, XVII International AIDS Conference. 2008, August , MOAA0105
16.
go back to reference Thibault S, et al: TLR2 and 5 stimulations increase HIV-1 integration in human naïve and memory CD4+ T cells. Abstract Session, XVII International AIDS Conference. 2008, August , THAA0405 Thibault S, et al: TLR2 and 5 stimulations increase HIV-1 integration in human naïve and memory CD4+ T cells. Abstract Session, XVII International AIDS Conference. 2008, August , THAA0405
17.
go back to reference Brann T, et al: S100A8 and S100A9, endogenous toll-like receptor 4 (TLR4) ligands, inhibit HIV-1 replication in macrophages but not in CD4 T cells. Poster Discussion, XVII International AIDS Conference. 2008, August , THPDA201 Brann T, et al: S100A8 and S100A9, endogenous toll-like receptor 4 (TLR4) ligands, inhibit HIV-1 replication in macrophages but not in CD4 T cells. Poster Discussion, XVII International AIDS Conference. 2008, August , THPDA201
18.
go back to reference Lisco A, et al: Local modulation of HIV-1 infection by non-HIV microbes in human tissues. Poster Exhibition, XVII International AIDS Conference. 2008, August , WEPE0134 Lisco A, et al: Local modulation of HIV-1 infection by non-HIV microbes in human tissues. Poster Exhibition, XVII International AIDS Conference. 2008, August , WEPE0134
19.
go back to reference Oh DY, et al: A Functional Toll-Like Receptor 8 Variant Is Associated with HIV Disease Restriction. Journal of Infectious Diseases. 2008, 198: 701-709. 10.1086/590431.CrossRefPubMed Oh DY, et al: A Functional Toll-Like Receptor 8 Variant Is Associated with HIV Disease Restriction. Journal of Infectious Diseases. 2008, 198: 701-709. 10.1086/590431.CrossRefPubMed
20.
go back to reference Schlaepfer E, Speck RF: Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering. PLoS ONE. 2008, 3: e1999-10.1371/journal.pone.0001999.PubMedCentralCrossRefPubMed Schlaepfer E, Speck RF: Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering. PLoS ONE. 2008, 3: e1999-10.1371/journal.pone.0001999.PubMedCentralCrossRefPubMed
21.
go back to reference Nuvor SV, et al: Expression of activating and inhibitory receptors on NK cells in HIV-1 and HIV-2 infections and functional assessment of direct NK cytolysis against autologous CD4+ T cells. Abstract Session, XVII International AIDS Conference. 2008, August , WEAA0203 Nuvor SV, et al: Expression of activating and inhibitory receptors on NK cells in HIV-1 and HIV-2 infections and functional assessment of direct NK cytolysis against autologous CD4+ T cells. Abstract Session, XVII International AIDS Conference. 2008, August , WEAA0203
22.
go back to reference Munier ML, Kelleher AD: Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol. 2007, 85: 6-15. 10.1038/sj.icb.7100015.CrossRefPubMed Munier ML, Kelleher AD: Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol. 2007, 85: 6-15. 10.1038/sj.icb.7100015.CrossRefPubMed
23.
go back to reference Conrad J, et al: PD-1 expression is increased on dominant T-cell clonotypes within HIV epitope-specific T-cell populations in chronic HIV infection. Abstract Session, XVII International AIDS Conference. 2008, August , TUAA0101 Conrad J, et al: PD-1 expression is increased on dominant T-cell clonotypes within HIV epitope-specific T-cell populations in chronic HIV infection. Abstract Session, XVII International AIDS Conference. 2008, August , TUAA0101
24.
go back to reference Lichterfeld M, et al: Distinct expression pattern of telomere maintenance and shelterin genes in HIV-1-specific CD8+ T cells from HIV-1 "elite" controllers. Abstract Session, XVII International AIDS Conference. 2008, August , THAA0201 Lichterfeld M, et al: Distinct expression pattern of telomere maintenance and shelterin genes in HIV-1-specific CD8+ T cells from HIV-1 "elite" controllers. Abstract Session, XVII International AIDS Conference. 2008, August , THAA0201
25.
go back to reference Lester RAT, et al: Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS. 2008, 22: 685-694. 10.1097/QAD.0b013e3282f4de35.CrossRefPubMed Lester RAT, et al: Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS. 2008, 22: 685-694. 10.1097/QAD.0b013e3282f4de35.CrossRefPubMed
26.
go back to reference Munier ML, Kelleher AD: Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol. 2007, 85: 6-15. 10.1038/sj.icb.7100015.CrossRefPubMed Munier ML, Kelleher AD: Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol. 2007, 85: 6-15. 10.1038/sj.icb.7100015.CrossRefPubMed
Metadata
Title
XVII International AIDS Conference: From Evidence to Action - Basic science
Authors
David Gilden
Rodney Kort
Publication date
01-12-2009
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-12-S1-S3

Other articles of this Special Issue 1/2009

Journal of the International AIDS Society 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.